WallStSmart
IRON

Disc Medicine Inc.

NASDAQ: IRON · HEALTHCARE · BIOTECHNOLOGY

$69.23
-5.78% today

Updated 2026-06-05

Market cap
$2.60B
P/E ratio
P/S ratio
EPS (TTM)
$-6.64
Dividend yield
52W range
$40 – $100
Volume
0.4M

Disc Medicine Inc. (IRON) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item202020212022202320242025
Operating cash flow$-32.71M$-27.53M$-42.25M$-73.46M$-93.93M$-180.39M
Capital expenditures$22000.00$68000.00$151000.00$89000.00$505000.00$933000.00
Depreciation
Stock-based comp$983000.00$507000.00$2.09M$5.53M$16.82M$34.34M
Free cash flow$-32.73M$-27.60M$-42.40M$-73.55M$-94.43M$-181.33M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

How much free cash flow does IRON generate?

IRON produced $-181.33M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is IRON's balance sheet healthy?

IRON holds $91.14M in cash and equivalents against $29.16M in long-term debt, on $739.83M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.